期刊
FEBS LETTERS
卷 582, 期 25-26, 页码 3614-3618出版社
WILEY
DOI: 10.1016/j.febslet.2008.09.040
关键词
Ascorbic acid; Adenylate cyclase; Gene expression; CMT disorder
资金
- ANR Maladies Rares
Recently, using an animal model of Charcot-Marie-Tooth human disorder, we showed that ascorbic acid ( AA) represses PMP22 gene expression by acting on intracellular cAMP concentrations. In this work, we present kinetics data on the inhibitory effect of AA upon adenylate cyclase activity. The data show that this molecule acts as a competitive inhibitor of the enzyme, a finding that opens new pharmacological avenues. (c) 2008 Published by Elsevier B. V. on behalf of the Federation of European Biochemical Societies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据